Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Parnax Lab Ltd Performance

Today's Low
111.05
arrowIcon
Today's High
117.00
52 Wk Low
55.00
arrowIcon
52 Wk High
167.90


Open

117

Traded Value (Cr)

3.42 L

Prev. Close

115.4

VWAP

113.59

Volume

2,986

Face Value

10

Parnax Lab Ltd Fundamentals

Market Cap
₹ 132 Cr
P/E Ratio (TTM)
14.99
P/B Ratio
1.96
Debt to Equity
0.88
ROE
14.52 %
EPS (TTM)
7.67
Dividend Yield
0.00%
Book Value
58.63

Click here to know more about Fundamentals

Parnax Lab Ltd Financials

Parnax Lab Ltd Financials

Parnax Lab Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 72.30 % 72.30 % 72.30 % 72.30 %
Retail 24.45 % 24.46 % 24.88 % 24.86 %
Others 3.26 % 3.25 % 2.83 % 2.84 %
FII 0.00 % 0.00 % 0.00 % 0.00 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %

Promoters

72.30%

Retail

24.45%

Others

3.26%

FII

0.00%

Mutual Funds

0.00%

Promoters

72.30%

Retail

24.46%

Others

3.25%

FII

0.00%

Mutual Funds

0.00%

Promoters

72.30%

Retail

24.88%

Others

2.83%

FII

0.00%

Mutual Funds

0.00%

Promoters

72.30%

Retail

24.86%

Others

2.84%

FII

0.00%

Mutual Funds

0.00%

Resistance and Support

₹116.90

PIVOT

resistance-arrow
Resistance
First Resistance₹118.800
Second Resistance₹122.600
Third Resistance₹124.500
support-arrow
Support
First Resistance₹113.100
Second Resistance₹111.200
Third Resistance₹107.400
RSI17.935
MACD-11.384
ADX10.471
CCI-132.315

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day10,34010,340100.00
Week10,38210,382100.00
1 Month14,51214,512100.00
6 Months000.00

About Parnax Lab Ltd

Parnax Lab Limited (Formerly Known as Krishna Deep Trade & Investment Ltd ) was incorporated in August, 1982. The Company changed the name from Krishna Deep Trade & Investment Ltd to Parnax Lab Limited effective on July 19, 2012. The Company is principally engaged in the business activities of manufacturing and export of Pharmaceutical Formulations. Initially, it was engaged in investment and financing activities. Naxpar Pharma Private Limited is Subsidiary Company of the Holding Company. With over two decades of rich experience behind it, the Naxpar Group is at the helm of innovation in the manufacturing of Pharmaceuticals, Cosmetics, Herbal/Ayurvedic formulations & Nutraceuticals (FSSAI) products. The Naxpar Group is headquartered in Mumbai, India. It is as a result of their diligence and perseverance that Naxpar's prowess in pharmaceutical manufacturing has seen exponential growth and achievement, significant milestones such as the coveted ISO 9002 status from RWTUV, Germany for following Good Quality Systems in manufacturing and marketing of formulations for domestic and international markets. Naxpar initially began as a single-establishment - indicative of its resounding success and growing client base, the Company now has state-of-the-art accredited manufacturing facilities with high speed packing lines in Silvassa, in Dadra & Nagar Haveli and Baddi in Himachal Pradesh. Naxpar's key strength is manufacturing finished formulations for multinationals in India and abroad and in emerging pharmaceutical markets such as Nigeria, Kazakhstan, Kenya, Mauritius etc. The WHO-approved and EHS-compliant Company is now well placed to venture into markets such as South East Asia, CIS, LatAm etc. where it is keen to establish its presence as a leading pharmaceuticals, cosmetics and herbal products manufacturer.

Managing Director

Baiju M Shah

Founded

1982

NSE Symbol

Parnax Lab Ltd Management

NameDesignation
Vindyak B DesaiIndependent Director
Prakash M ShahDirector & Chief Executive Off
Baiju M ShahManaging Director & CFO
Ami M ShahNon Executive Director
T V AnantharamanIndependent Director
Yogesh VariaIndependent Director
Harish S PanpaliaIndependent Director

Parnax Lab Ltd News

Parnax Lab consolidated net profit declines 30.79% in the December 2023 quarter
Sales rise 8.91% to Rs 50.99 crore
Parnax Lab to announce Quarterly Result
On 13 February 2024
Parnax Lab consolidated net profit declines 10.95% in the September 2023 quarter
Sales decline 1.23% to Rs 42.61 crore
Parnax Lab to hold board meeting
On 9 November 2023
Parnax Lab schedules AGM
On 29 September 2023
Parnax Lab consolidated net profit rises 72.02% in the June 2023 quarter
Sales rise 32.66% to Rs 48.74 crore
Parnax Lab to table results
On 11 August 2023
Parnax Lab reports consolidated net profit of Rs 1.44 crore in the March 2023 quarter
Sales decline 14.61% to Rs 40.91 crore
Parnax Lab to conduct board meeting
On 30 May 2023
Parnax Lab consolidated net profit declines 30.77% in the December 2022 quarter
Sales decline 7.62% to Rs 46.82 crore

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
SUNPHARMA₹ 3,58,304 Cr
₹ 1,505.20
(0.79 %)
86.97
CIPLA₹ 1,09,708 Cr
₹ 1,339.45
(-1.42 %)
33.36
DIVISLAB₹ 1,00,599 Cr
₹ 3,791.10
(0.04 %)
73.75
DRREDDY₹ 98,073 Cr
₹ 5,922.45
(0.74 %)
22.59
ZYDUSLIFE₹ 97,383 Cr
₹ 983.05
(1.58 %)
36.23

Parnax Lab Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Parnax Lab Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Parnax Lab Ltd's share price is ₹114.50 as of May 10, 2024

Parnax Lab Ltd's P/E ratio is 14.99 times as of May 10, 2024.

Parnax Lab Ltd's most recent financial reports indicate a price-to-book ratio of 1.96, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Parnax Lab Ltd's market is 132 Cr as on May 10, 2024.

The current financial records of Parnax Lab Ltd show a 14.52% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Parnax Lab Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Parnax Lab Ltd's 52-week high and low as of May 10, 2024 are ₹117 and ₹111.05 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Parnax Lab Ltd stands at 72.30%. During the same period, Institutional Investors have shown a slight values are equal in their holdings, values are equal from 0.00% to 0.00%.